A securities class action has been filed in the USDC — C.D.CA. against Aehr Test Systems, Inc. (AEHR) (“Aehr” or the “Company”), on behalf of all those that purchased or otherwise acquired Aehr securities between January 9, 2024, and March 24, 2024, both dates inclusive (the “Class Period”).

Aehr provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide.

The complaint alleges defendants made false and/or misleading statements and/or failed to disclose that:

(1) contrary to prior representations to investors, Aehr was continuing to experience substantial delays in customer orders;

(2) the foregoing issue was likely to have a material negative impact on the Company’s revenue growth;

(3) accordingly, the Company’s business and/or financial prospects were overstated; and

(4) as a result, the Company’s public statements were materially false and misleading at all relevant times, thereby harming investors.

On this news, Aehr’s stock price fell $3.29 per share, or 22.44%, to close at $11.37 per share on March 25, 2024.

If you purchased Aehr securities during the class period and would like to receive more information or join the action, please enter your contact information below for a FREE consultation and click “Submit Your Information.”

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.